NCT01687205View on ClinicalTrials.gov

Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

November 30, 2014

Conditions
Pharmacokinetics of 1% Tenofovir Gel Following CoitusPharmacodynamics of 1% Tenofovir Gel Following Coitus
Interventions
DRUG

1% Tenofovir Gel

Trial Locations (2)

15213

Magee-Womens Hospital of UPMC, Pittsburgh

44106

Case Western Reserve University, Cleveland

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

CONRAD

OTHER

NCT01687205 - Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel | Biotech Hunter | Biotech Hunter